Phase 1 Tooth Disease Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1Phase 2

Study of Intrathecal ELP-02 for Charcot-Marie-Tooth Disease Type 4J (CMT4J)

Charcot-Marie-Tooth Disease Type 4J

Elpida Therapeutics SPC8 enrolled2 locationsNCT07447557

Recruiting

Phase 1Phase 2

Evaluate the Safety and Efficacy of EN001 in Patients With Charcot-Marie-Tooth Disease Type 1A(CMT1A) (Phase 1b: Open-label, Dose-escalation, Single-center; Phase 2a: Randomized, Double-blind, Placebo-controlled, Multicenter)

Charcot-Marie-Tooth Disease, Type 1A

ENCell27 enrolled3 locationsNCT06328712

Recruiting

Phase 1

A First in Human Study to Assess the Safety, Tolerability, and Pharmacokinetics of EDK060 in Adults With CMT1A.

Charcot-Marie-Tooth Disease, Type 1A

Novartis Pharmaceuticals28 enrolled3 locationsNCT07140614